Medicines and health technology adoption

Life science innovation demands significant investment, robust clinical evidence and regulatory approval — yet even with these in place, progress can stall when it reaches everyday clinical practice. Adoption often slows because: • Clinical guidance is hard to translate into day‑to‑day workflows • Identifying eligible patients at scale is challenging • Uptake varies widely across regions and care settings • Clinicians are under intense pressure, with limited time and visibility These challenges aren’t driven by a lack of clinical intent. They reflect the realities of a stretched, fragmented healthcare system — where even proven innovations can struggle to reach the patients who would benefit most. Where innovation slows

4

5